EU Extends Inspection Of Teva-Barr Deal
The European Commission extended its inspection of the proposed merger from Dec. 8 to Dec. 22 as it takes a look at remedies to mitigate potential risks to competition, according to the EC’s daily list of mergers under review.
In a first-phase merger inquiry, there is an automatic 10-working-day extension of the deadline if the parties offer remedies,...
Already a subscriber? Click here to login